Monika Looney
Postdoctoral Research Fellow South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town (UCT), South Africa Email: monika.looney@uct.ac.za
VALIDATE Role: Network Associate
Research Keywords: TB, TB Vaccines, Single Cell RNA Sequencing, Immunology
Biography: Dr. Looney is deeply passionate about ending TB. She received her PhD (2021) in Pathobiology from the Johns Hopkins School of Medicine, Department of Pathology. She conducted her thesis work on the dysregulation of small RNAs and methylation in human macrophages during infection with Mycobacterium tuberculosis in the lab of Professor Petros Karakousis, Center for Tuberculosis Research. During her graduate studies, she also received a Certificate in Global Health from the Johns Hopkins Bloomberg School of Public Health (2020). Dr. Looney is currently completing her Postdoctoral Research Fellowship in single cell immunology at the South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town (UCT). Her research focuses on understanding human immunological responses to the antigens included in the novel TITAN mRNA TB vaccine and on using single cell RNA sequencing and immunophenotyping to identify immune correlates of protection elicited by the M72:AS01E TB vaccine candidate.
Related Websites:
Key Publications:
|
